Seer (SEER)
(Delayed Data from NSDQ)
$1.75 USD
-0.02 (-1.13%)
Updated Apr 25, 2024 04:00 PM ET
Pre-Market: $1.80 +0.05 (2.86%) 9:26 AM ET
3-Hold of 5 3
D Value D Growth B Momentum F VGM
Price, Consensus and EPS Surprise
SEER 1.75 -0.02(-1.13%)
Will SEER be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for SEER based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for SEER
BioMarin Pharmaceutical (BMRN) Tops Q1 Earnings Estimates
Seer, Inc. (SEER) Reports Q4 Loss, Tops Revenue Estimates
SEER: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why Seer, Inc. (SEER) Could be Great Choice for a Bottom Fisher
Seer, Inc. (SEER) Reports Q3 Loss, Tops Revenue Estimates
Seer, Inc. (SEER) Reports Q2 Loss, Misses Revenue Estimates
Other News for SEER
Seer to Report First Quarter 2024 Financial Results on May 8, 2024
Candel Therapeutics receives FDA orphan drug designation for its pancreatic cancer treatment
New Share Price & Shareholder Rights Risk for Seer, Inc. – What’s the Latest?
Seer assumed with an Equal Weight at Morgan Stanley
Seer, Inc. (SEER) Q4 2023 Earnings Call Transcript